GRIN Therapeutics

New York, United States

GRIN Therapeutics is at the forefront of developing targeted therapies for rare, severe neurodevelopmental disorders.

$140.0M raised

May 2025

Series D

Biotechnology Medical Therapeutics

Top Investors

Blackstone Life Sciences Angelini Pharma

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about GRIN Therapeutics

How much funding has GRIN Therapeutics raised?

GRIN Therapeutics has raised $140.0M in total funding. The most recent round was Series D. The last funding was announced in May 2025.

Who are GRIN Therapeutics's investors?

GRIN Therapeutics's investors include Blackstone Life Sciences, Angelini Pharma.

Where is GRIN Therapeutics headquartered?

GRIN Therapeutics is headquartered in New York, United States.

What does GRIN Therapeutics do?

GRIN Therapeutics is at the forefront of developing targeted therapies for rare, severe neurodevelopmental disorders.

What stage is GRIN Therapeutics at?

GRIN Therapeutics is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 27, 2025.

MLA

"GRIN Therapeutics — Funding & Investors." VCBacked, May 27, 2025, https://www.vcbacked.co/company/grin-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2025). GRIN Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/grin-therapeutics

Wikipedia (cite web)

{{cite web |title=GRIN Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/grin-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 27, 2025.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K